{"id":"https://openalex.org/W2481068577","doi":"https://doi.org/10.1371/journal.pone.0159328","title":"Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics","display_name":"Use of In Vitro Assays to Assess Immunogenicity Risk of Antibody-Based Biotherapeutics","alternate_titles":[],"publication_year":2016,"publication_date":"2016-08-05","ids":{"openalex":"https://openalex.org/W2481068577","doi":"https://doi.org/10.1371/journal.pone.0159328","mag":"2481068577","pmid":"https://pubmed.ncbi.nlm.nih.gov/27494246","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4975389"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0159328","doi":"https://doi.org/10.1371/journal.pone.0159328","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0159328","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159328&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2481068577"],"child_works_count":11,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159328&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091041620","display_name":"Marisa K. Joubert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marisa K. Joubert","raw_affiliation_strings":["Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Meghana Deshpande","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meghana Deshpande","raw_affiliation_strings":["Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jane Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jane Yang","raw_affiliation_strings":["Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077197480","display_name":"Helen Reynolds","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Helen Reynolds","raw_affiliation_strings":["Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022609038","display_name":"Christine J. Bryson","orcid":"https://orcid.org/0000-0002-2365-4395","observed_orcids":["https://orcid.org/0000-0002-2365-4395"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christine Bryson","raw_affiliation_strings":["Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018487216","display_name":"Mark H. Fogg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Fogg","raw_affiliation_strings":["Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065921861","display_name":"Matthew Baker","orcid":"https://orcid.org/0000-0003-0053-163X","observed_orcids":["https://orcid.org/0000-0003-0053-163X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew P. Baker","raw_affiliation_strings":["Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Antitope Limited, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090349455","display_name":"Jonathan Herskovitz","orcid":"https://orcid.org/0000-0003-1084-6838","observed_orcids":["https://orcid.org/0000-0003-1084-6838"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jonathan Herskovitz","raw_affiliation_strings":["Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059439638","display_name":"Theresa J. Goletz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Theresa J. Goletz","raw_affiliation_strings":["Department of Clinical Immunology, Amgen Inc., Seattle, Washington, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Amgen Inc., Seattle, Washington, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085081570","display_name":"Lei Zhou","orcid":"https://orcid.org/0000-0002-8837-3965","observed_orcids":["https://orcid.org/0000-0002-8837-3965"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lei Zhou","raw_affiliation_strings":["Department of Medical Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088684470","display_name":"Michael S. Moxness","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael Moxness","raw_affiliation_strings":["Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035284210","display_name":"Gregory C. Flynn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gregory C. Flynn","raw_affiliation_strings":["Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111039128","display_name":"Linda Owers Narhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Linda O. Narhi","raw_affiliation_strings":["Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Attribute Sciences, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104667324","display_name":"Vibha Jawa","orcid":"https://orcid.org/0000-0001-7019-729X","observed_orcids":["https://orcid.org/0000-0001-7019-729X","https://orcid.org/0000-0002-6463-4729"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Vibha Jawa","raw_affiliation_strings":["Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Immunology, Amgen Inc., Thousand Oaks, California, United States of America","institution_ids":["https://openalex.org/I1320553840"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5091041620","https://openalex.org/A5104667324"],"corresponding_institution_ids":["https://openalex.org/I1320553840"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":5.0169,"has_fulltext":true,"cited_by_count":129,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9618246,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"11","issue":"8","first_page":"e0159328","last_page":"e0159328"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9907000064849854,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11124","display_name":"Protein purification and stability","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunogenicity-risk-assessment","display_name":"immunogenicity risk assessment","score":0.8650000095367432},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9639999866485596},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.9629999995231628},{"id":"https://openalex.org/keywords/cytokine-production","display_name":"cytokine production","score":0.7699999809265137},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.8379999995231628},{"id":"https://openalex.org/keywords/protein-aggregation","display_name":"protein aggregation","score":0.7070000171661377},{"id":"https://openalex.org/keywords/glycation","display_name":"glycation","score":0.671999990940094},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9229999780654907},{"id":"https://openalex.org/keywords/biopharmaceutical-development","display_name":"biopharmaceutical development","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.961974561214447},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.687758207321167},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5311497449874878},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.5020174980163574},{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.48600396513938904},{"id":"https://openalex.org/C33618052","wikidata":"https://www.wikidata.org/wiki/Q6013136","display_name":"In vitro toxicology","level":3,"score":0.4100499153137207},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3743671178817749},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35046613216400146},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3248841166496277},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.322569340467453},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16573747992515564}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D017354","descriptor_name":"Point Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058501","descriptor_name":"Enzyme-Linked Immunospot Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1371/journal.pone.0159328","doi":"https://doi.org/10.1371/journal.pone.0159328","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0159328","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159328&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4975389","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4975389/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmid:27494246","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27494246","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:11036b583ad64fa0a8d65d9be60461ff","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/11036b583ad64fa0a8d65d9be60461ff","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 11, Iss 8, p e0159328 (2016)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/3868101","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/Use_of_i_In_Vitro_i_Assays_to_Assess_Immunogenicity_Risk_of_Antibody-Based_Biotherapeutics/3868101","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0159328","doi":"https://doi.org/10.1371/journal.pone.0159328","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0159328","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0159328&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLOS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2481068577.pdf","grobid_xml":"https://content.openalex.org/works/W2481068577.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W122446176","https://openalex.org/W1661544713","https://openalex.org/W1673822629","https://openalex.org/W1950293547","https://openalex.org/W1967295501","https://openalex.org/W1968287902","https://openalex.org/W1971968909","https://openalex.org/W1980850179","https://openalex.org/W1984966253","https://openalex.org/W1988718462","https://openalex.org/W1991047550","https://openalex.org/W1993285681","https://openalex.org/W1993511309","https://openalex.org/W2001809800","https://openalex.org/W2008138329","https://openalex.org/W2011684044","https://openalex.org/W2011946439","https://openalex.org/W2013361256","https://openalex.org/W2018922312","https://openalex.org/W2024168294","https://openalex.org/W2033536775","https://openalex.org/W2046811689","https://openalex.org/W2048087821","https://openalex.org/W2051721310","https://openalex.org/W2054260142","https://openalex.org/W2061357129","https://openalex.org/W2067197313","https://openalex.org/W2069206672","https://openalex.org/W2071095038","https://openalex.org/W2091360431","https://openalex.org/W2100350770","https://openalex.org/W2111358490","https://openalex.org/W2114029270","https://openalex.org/W2114964760","https://openalex.org/W2126468249","https://openalex.org/W2137879329","https://openalex.org/W2138317859","https://openalex.org/W2143380331","https://openalex.org/W2145250332","https://openalex.org/W2155294390","https://openalex.org/W2164309192","https://openalex.org/W2167777181","https://openalex.org/W2281597363"],"related_works":["https://openalex.org/W4399097685","https://openalex.org/W4412556677","https://openalex.org/W2985494309","https://openalex.org/W4386530330","https://openalex.org/W4311050081","https://openalex.org/W7155490539","https://openalex.org/W3042894437","https://openalex.org/W2949367361","https://openalex.org/W3136945858","https://openalex.org/W2152712154"],"abstract_inverted_index":{"An":[0],"In":[1,172],"Vitro":[2],"Comparative":[3],"Immunogenicity":[4],"Assessment":[5],"(IVCIA)":[6],"assay":[7,64,82,99,119,149,194,206,237],"was":[8,69,120,207],"evaluated":[9],"as":[10],"a":[11,55,101,144,158],"tool":[12],"for":[13,40,233,238],"predicting":[14],"the":[15,43,52,63,76,81,95,98,108,132,148,151,164,169,193,196,199,218,223,235,243],"potential":[16],"relative":[17,165],"immunogenicity":[18,87,112,239],"of":[19,45,54,57,90,103,131,168,217,247],"biotherapeutic":[20,92],"attributes.":[21,93],"Peripheral":[22],"blood":[23],"mononuclear":[24],"cells":[25],"from":[26,222,227],"up":[27,36],"to":[28,37,65,71,86,122,187,198,211],"50":[29],"healthy":[30],"na\u00efve":[31],"human":[32],"donors":[33],"were":[34,138,176],"monitored":[35],"8":[38],"days":[39],"T-cell":[41,104,166],"proliferation,":[42],"number":[44],"IL-2":[46],"or":[47],"IFN-\u03b3":[48],"secreting":[49],"cells,":[50],"and":[51,107,125,183,226],"concentration":[53],"panel":[56],"secreted":[58],"cytokines.":[59],"The":[60,118,205],"response":[61,96,146,167,191,197],"in":[62,73,97,147,157,190,192],"10":[66],"monoclonal":[67],"antibodies":[68],"found":[70],"be":[72,84],"agreement":[74],"with":[75,110],"clinical":[77,111],"immunogenicity,":[78],"suggesting":[79],"that":[80,137,160,175],"might":[83],"applied":[85],"risk":[88,240],"assessment":[89,241],"antibody":[91],"However,":[94],"is":[100,249],"measure":[102],"functional":[105],"activity":[106],"alignment":[109],"depends":[113],"on":[114],"several":[115],"other":[116],"factors.":[117],"sensitive":[121],"sequence":[123],"variants":[124],"could":[126],"differentiate":[127],"single":[128],"point":[129],"mutations":[130],"same":[133,219,224],"biotherapeutic.":[134],"Nine":[135],"mAbs":[136,153,174,201],"highly":[139],"aggregated":[140],"by":[141,178],"stirring":[142,155],"induced":[143],"higher":[145],"than":[150],"original":[152,170,200],"before":[154,202],"stress,":[156],"manner":[159],"did":[161],"not":[162],"match":[163],"mAbs.":[171],"contrast,":[173],"glycated":[177],"different":[179,228],"sugars":[180],"(galactose,":[181],"glucose,":[182],"mannose)":[184],"showed":[185],"little":[186],"no":[188],"increase":[189],"above":[195],"glycation":[203],"treatment.":[204],"also":[208],"used":[209],"successfully":[210],"assess":[212],"similarity":[213],"between":[214],"multiple":[215],"lots":[216],"mAb,":[220],"both":[221],"manufacturer":[225],"manufacturers":[229],"(biosimilars).":[230],"A":[231],"strategy":[232],"using":[234],"IVCIA":[236],"during":[242],"entire":[244],"lifespan":[245],"development":[246],"biopharmaceuticals":[248],"proposed.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2481068577","counts_by_year":[{"year":2026,"cited_by_count":9},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-08-23T00:00:00"}
